Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants

Condition(s) studied

Investigational drug(s) / intervention(s)

Implant Treatment: Surgical placement of a DS Prime Taper implant and its posterior prosthesis.

Study summary

The DS Prime Taper EV dental implant system was recently launched on the implant market by Dentsply Sirona (York, PA, USA).

Dental implant systems are undergoing rapid evolution, ultimately driven by their broad therapeutic indications. As manufacturers strive to keep up with the demands of a growing market, designs are changing faster than clinical evaluation. This means that the time needed to assess medium- and long-term clinical outcomes before designs change again cannot be met.

Clinicians need to have a "real" analysis of the clinical performance of implants before using them. Therefore, reporting of results is necessary to avoid use in patients without proper practical checks even before the recommended 10- and 15-year follow-up periods.

Eligibility

Primary outcome measure(s)

• Implant Survival Rate — through study completion, an average of 1 year
  Time of survival of DS Prime Taper dental implant placed
• Implant Success Rate — through study completion, an average of 1 year
  Radiological assessment of Marginal Bone Levels around DS Prime Taper implants in function
• Biological and mechanical complications events — through study completion, an average of 1 year
  All type of complications that may occur during implant survival

Trial sites (1)

More Aula Dental Avanzada trials in Spain

Other trials for the same condition